Reference of Weight Loss Drugs

Reference for Weight Loss Drugs

1. Coutinho W. The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions. Arq Bras Endocrinol Metab. 2009;53/2: 262-70.
2. Tziomalos K, Krassas G, Tzotzas T. The use of sibutramine in the management of obesity and related disorders: An update. Vascular Health and Risk Management 2009:5 441–452
3. Leite C, Mocelin CA, Petersen GO, Leal MB, Thiesen FV. Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity. Pharmacological Reports 2009, 61:217-224
4. Questions and Answers about FDA’s Initiative Against Contaminated Weight Loss Products- (http://www.fda.gov/Drugs/ResourcesForYou/Consumers/QuestionsAnswers/ucm136187.htm)

Author: Dr. Trupti Shirole

Editor: Dr. Simi Paknikar

Technically Checked by: Lingaraj